RFK Jr. cancels $500 million in mRNA vaccine funding

Robert F. Kennedy Jr. has reportedly influenced the US government's decision to withdraw $500 million in funding for mRNA vaccine research, claiming the technology poses "more risk than benefit." This move signals a shift in priorities and raises questions about the future of mRNA-based medical innovations.

Robert F. Kennedy Jr. has announced the cancellation of $500 million in funding for vaccine development, specifically targeting mRNA vaccines. In a video statement, he criticized the technology and halted projects involving major pharmaceutical companies.

Robert F. Kennedy Jr. has canceled contracts worth nearly $500 million related to mRNA vaccines, signaling a major shift in his organization's stance or strategy regarding these vaccines. The move could have significant financial and political implications, especially given Kennedy's vocal criticism of vaccine mandates and mRNA technology.

Robert F. Kennedy Jr.'s administration is cutting $500 million in funding for vaccine development, specifically targeting contracts for respiratory virus vaccines like COVID-19 and the flu. The Department of Health and Human Services is canceling these contracts, which could slow down or halt progress on these vaccines.

The Trump administration, under Health and Human Services Secretary Robert F. Kennedy Jr., is canceling 22 contracts worth $500 million that were aimed at developing mRNA vaccines. Additionally, the government is scaling back further federal funding for mRNA technology.